Unraveling the therapeutic landscape of approved non-peptide macrocycles
Non-peptide macrocyclic drugs possess unique structural advantages that allow them to target various biomolecules of interest and thus show therapeutic potential against various diseases such as cancer, infectious diseases, etc. This review article examines 34 non-peptide macrocyclic drugs approved...
Saved in:
| Main Authors: | Zhonghua Li, Zhenqiang Zhang, Bin Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525002801 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macrocyclic lactones and ectoparasites control in livestock: Efficacy, drug resistance and therapeutic challenges
by: A. Lifschitz, et al.
Published: (2024-12-01) -
From Synthesis to Application: Advances in Macrocyclic Complexes
by: Nabaa Abbas, et al.
Published: (2025-07-01) -
Sucrose-Based Macrocycles: An Update
by: Sławomir Jarosz, et al.
Published: (2025-06-01) -
Macrocyclic Azopyrrole: Synthesis, Structure and Fluoride Recognition
by: Ying An, et al.
Published: (2025-06-01) -
Surveillance of single nucleotide polymorphisms correlated to macrocyclic lactone resistance in Dirofilaria immitis from client-owned dogs across the United States
by: Emily Curry, et al.
Published: (2025-12-01)